Levetiracetam Accord

Levetiracetam, the active ingredient in Levetiracetam Accord, is an anticonvulsant presented as an oral tablet for oral use. It treats various seizure types in patients with epilepsy.

GNH USA supplies Levetiracetam Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic drug used to control seizure activity across several epilepsy syndromes.

- Partial seizures: reduces the frequency of focal onset seizures. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes. - Myoclonic seizures: decreases sudden muscle jerks associated with myoclonic epilepsy.

Levetiracetam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dizziness: sensation of light‑headedness or imbalance. - Headache: mild to moderate cranial pain. - Irritability: mood changes or increased agitation. - Nausea: upset stomach or feeling of queasiness. - Nasal congestion: blocked or runny nose.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Mood disorders: depression, suicidal thoughts, or aggressive behavior. - Hematologic changes: low blood cell counts or abnormal clotting. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Patients should be aware of specific safety considerations when using Levetiracetam.

- Pregnancy: Category B – use only if clearly needed after risk‑benefit assessment. - Renal function: dose may require adjustment in impaired kidney function. - Mood monitoring: watch for depression, anxiety, or suicidal ideation. - Concomitant CNS depressants: may enhance sedation or dizziness. - Driving and machinery: avoid until individual response is known. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Levetiracetam can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenobarbital: may lower levetiracetam exposure.

Moderate Interactions (Monitor Closely): - Alcohol: can increase central nervous system depression. - Other antiepileptics (e.g., valproate, lamotrigine): may require dose adjustments. - Oral contraceptives: limited data, monitor for reduced effectiveness.